Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation
Cisplatin is the most common antineoplastic drug used for the therapy of solid tumours. To date, researchers have focused on the dosage to be administered for each specific tumour, mainly considering the local adverse effects. The aim of this study was to correlate the severity of the adverse effect...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | angličtina |
| Vydáno: |
2013
|
| On-line přístup: | https://doi.org/10.3892/or.2013.2279 https://www.spandidos-publications.com/or/29/4/1285/download |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|